A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2011
12/29/2011	US20110318343 Stable Liquid Pharmaceutical Formulation Of IgG Antibodies
12/29/2011	US20110318331 Nanoparticles and Use Thereof
12/29/2011	US20110318322 Conjugates of a Lysosomal Enzyme Moiety and a Water Soluble Polymer
12/29/2011	US20110318297 Single protein nanocapsules for protein delivery with long-term effect
12/29/2011	US20110318285 Personal care composition additive for application on keratin substrates to provide long lasting benefits
12/29/2011	US20110318267 Ph-responsive nanostructures
12/29/2011	DE102010024866A1 Formulierung zur Geschmacksmaskierung Formulation for taste masking
12/29/2011	CA2840431A1 Compositions and methods for treatment of thrombosis and for prolonging survival of stored platelets
12/29/2011	CA2840339A1 Lecithin carrier vesicles and methods of making the same
12/29/2011	CA2805449A1 Treatment of sanfilippo syndrome type b
12/29/2011	CA2803770A1 Process for producing emulsifier-producing material, process for producing emulsifier, emulsifier for orally administered composition, and orally administered composition
12/29/2011	CA2803556A1 Branched hetero polyethylene glycol and intermediate
12/29/2011	CA2803392A1 Dual variable domain immunoglobulins and uses thereof
12/29/2011	CA2803391A1 Colon and pancreas cancer specific antigens and antibodies
12/29/2011	CA2803258A1 Pharmaceutical composition comprising midazolam
12/29/2011	CA2803166A1 Cns delivery of therapeutic agents
12/29/2011	CA2803164A1 Amide-based insulin prodrugs
12/29/2011	CA2803029A1 Constrained immunogenic compositions and uses therefor
12/29/2011	CA2802932A1 Long-term storage of non-glycosylated recombinant human g-csf
12/29/2011	CA2802733A1 Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
12/29/2011	CA2802604A1 Taste-masked pharmaceutical formulation having accelerated onset of action
12/29/2011	CA2802463A1 Optimized in vivo delivery system with endosomolytic agents for nucleic acid conjugates
12/29/2011	CA2802209A1 Sustained-release formulation
12/29/2011	CA2801731A1 Topical ophthalmic suspensions containing tobramycin and dexamethasone
12/29/2011	CA2801098A1 Tolvaptan solid dispersion and its preparation method
12/29/2011	CA2796894A1 Amide based glucagon superfamily peptide prodrugs
12/29/2011	CA2796879A1 Dipeptide linked medicinal agents
12/29/2011	CA2745102A1 Pharmaceutical composition and method of use to improve organ function
12/28/2011	EP2399993A1 Hypo-immunogenic streptavidin and use thereof
12/28/2011	EP2399948A1 Cationic poly(amino acids) and uses thereof
12/28/2011	EP2399930A1 N-terminally monopegylated polypeptides and process for their preparation
12/28/2011	EP2399610A2 Polymer nanoparticles coated by magnetic metal oxide and uses thereof
12/28/2011	EP2399609A1 Process for preparing maytansinoid antibody conjugates
12/28/2011	EP2399608A1 Immunomodulating nanoparticulate composition for use in inhalation therapy
12/28/2011	EP2399607A1 Transdermal preparation
12/28/2011	EP2399586A1 Use of P97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
12/28/2011	EP2399574A1 Intraoral film-like base agent and formulation
12/28/2011	EP2399573A1 Compositions comprising poorly water soluble pharmaceutical agents
12/28/2011	EP2399571A1 Therapeutic compositions comprising ingenol-3-angelate
12/28/2011	EP2398895A2 Switchable affinity binders
12/28/2011	EP2398827A2 Improved anti-tnfr1 polypeptides, antibody variable domains&antagonists
12/28/2011	EP2398761A2 Controlled release of nitric oxide and drugs from functionalized macromers and oligomers
12/28/2011	EP2398500A2 Glutathione-based drug delivery system
12/28/2011	EP2398499A1 Bi-functional co-polymer use for ophthalmic and other topical and local applications
12/28/2011	EP2398465A1 A dermaceutical gel made using sodium fusidate&a process to make it
12/28/2011	EP2398461A1 Formulation comprising drospirenone for subcutaneous or intramuscular administration
12/28/2011	EP2398460A2 Particle size-structured parenteral dispersions
12/28/2011	EP2315580B1 Pharmaceutical formulations and methods for treating respiratory tract infections
12/28/2011	EP2291185B1 Octenidine composition
12/28/2011	EP2170332B1 A medicament for treating glaucoma comprising as an active ingredient cyclodextrin-clathrate compound of cilostazol
12/28/2011	EP1873240B1 hTERT GENE EXPRESSION REGULATORY GENE
12/28/2011	EP1857120B1 Infusion for mastitis
12/28/2011	EP1667716B1 Cytotoxicity mediation of cells evidencing surface expression of cd44
12/28/2011	EP1640022B1 Menthol-containing preparation
12/28/2011	EP1469745B1 Use of multi-layer pigments in the food and pharmaceutical industry
12/28/2011	EP1234033B1 Methods for targeting cells that express fibroblast growth factor receptor-3 or-2
12/28/2011	CN1993115B 2-氨基-1,3-丙二醇化合物的制剂 Formulation 2-amino-1,3-propanediol compound
12/28/2011	CN1907273B 烟碱透皮制剂的制备方法 Nicotine transdermal formulation preparation
12/28/2011	CN1774259B 治疗系统性红斑狼疮的肽的胃肠道外制剂 Parenteral preparations for treatment of systemic lupus erythematosus peptides
12/28/2011	CN1694728B 用于传递治疗剂的以环糊精为基础的聚合物 Polymers for delivery of therapeutic agents to a cyclodextrin-based
12/28/2011	CN1681483B 用于口服的改进释放低溶解度活性成分的微囊 Improved low solubility for oral administration the active ingredient release microcapsules
12/28/2011	CN102300588A 低聚物-吩噻嗪缀合物 Oligomer - phenothiazine conjugate
12/28/2011	CN102300586A 稳定的药物组合物，其含有至少一种单克隆抗体和至少一种包含疏水性取代基的两亲性多糖 Stable pharmaceutical composition comprising at least one monoclonal antibody and at least one substituent comprising a hydrophobic amphipathic polysaccharide
12/28/2011	CN102300576A 用包含黄芪提取物的组合物治疗特发性血小板减少性紫癜 The composition contains astragalus extract treatment of idiopathic thrombocytopenic purpura
12/28/2011	CN102300565A 口腔内薄膜状基剂及制剂 Intra-oral film-like formulations based agents
12/28/2011	CN102300563A 具有内核的口腔崩解片剂 Oral disintegrating tablet with a kernel
12/28/2011	CN102300559A 吡啶并嘧啶酮的固体口服制剂 Pyrido pyrimidinone solid oral preparations
12/28/2011	CN102300557A 用于治疗血管疾病的给药系统 For the treatment of vascular disease drug delivery system
12/28/2011	CN102300555A 复苏液 Fluid resuscitation
12/28/2011	CN102296056A 分枝杆菌噬菌体d29颗粒及其制备方法和应用 Mycobacteriophage d29 particle and its preparation method and application
12/28/2011	CN102295926A 一种荧光介孔氧化硅纳米材料及其制备方法和应用 A fluorescent mesoporous silica nano material and preparation method and application
12/28/2011	CN102295778A 一种超支化聚磷酰胺酯及其制备方法 One kind of hyperbranched poly phosphate ester amide and its preparation method
12/28/2011	CN102295773A 一种富勒烯封端的聚天门冬氨酸苄酯及其制备方法 One kind of fullerene-terminated poly aspartic acid benzyl ester and its preparation method
12/28/2011	CN102295772A 单甲氧基聚乙二醇-聚l-色氨酸两亲性嵌段共聚物及其制备方法以及其载药胶束溶液的制备方法 Monomethoxy-polyethylene glycol - poly-l- tryptophan amphiphilic block copolymer and its preparation method and preparation method of drug-loaded micelle solution
12/28/2011	CN102295768A 一种含单一活性功能基团的环形聚乙二醇及其制备方法 Circular polyethylene glycol and its preparation method containing the single active functional groups
12/28/2011	CN102295765A Copolycondensation synthesized polylactic acid-glycollic acid catalyzed by biomass creatinine
12/28/2011	CN102295737A 一种新型多响应性两亲聚氨酯及其制备方法 A new multi-responsive amphiphilic polyurethane and its preparation method
12/28/2011	CN102295706A 木纤维制备药用辅料交联羧甲基纤维素钠的方法 Wood fiber preparation of pharmaceutical excipients cross-linked sodium carboxymethyl cellulose method
12/28/2011	CN102294035A 一种双重靶向抗恶性肿瘤纳米载药系统及其制备方法 A dual-targeted anti-cancer nano drug delivery systems and its preparation method
12/28/2011	CN102294034A 一种生物矿化材料及其制备方法与应用 A biological mineralized material and its preparation method and application
12/28/2011	CN102294033A 一种球状颗粒乳糖的生产工艺 One kind of spherical particles of lactose production process
12/28/2011	CN102294025A 前列腺干细胞抗原多肽与核酸的复合物及其制备方法和应用 Prostate stem cell antigen peptide and nucleic acid compound and preparation method and application
12/28/2011	CN102294024A 一种多肽疫苗及其制备方法 A peptide vaccine and its preparation method
12/28/2011	CN102294023A 抗原组合物 Antigen composition
12/28/2011	CN102293997A 一种干姜提取物的制备方法 A ginger extract preparation method thereof
12/28/2011	CN102293986A 具有消炎、止痒和消毒杀菌功效的涂膜剂及其制备方法 Plaster and its preparation method has anti-inflammatory, anti-itching and disinfection efficacy
12/28/2011	CN102293984A 一种醒脑静冻干速释制剂及其制备方法与用途 One kind of immediate-release formulations Xingnaojing lyophilized preparation method and use
12/28/2011	CN102293889A 四磨汤干混悬剂及其制备方法 Simotang dry suspension and its preparation method
12/28/2011	CN102293829A 止痛外敷药及其制备方法 Analgesic for external application and its preparation method
12/28/2011	CN102293801A 一种川芎挥发油滴丸 One kind of volatile oil dropping pills
12/28/2011	CN102293794A 一种苏冰滴丸制剂及其制备 One kind of Su ice dripping pill and its preparation
12/28/2011	CN102293781A 低腐蚀性清洗液 Low corrosive cleaning fluid
12/28/2011	CN102293761A 含止吐剂成份的透皮吸收贴剂 Antiemetics ingredients containing transdermal patch
12/28/2011	CN102293760A 一种单硝酸异山梨酯择时控释制剂及其制备方法 When the controlled release formulation and preparation method isosorbide dinitrate selection
12/28/2011	CN102293759A 右旋布洛芬缓释片制剂及其制备方法 Dexibuprofen sustained release tablet formulation and preparation method
12/28/2011	CN102293758A 一种拉米夫定片及其制备方法 One kind of piece of lamivudine and its preparation method
12/28/2011	CN102293755A 两种甲泼尼龙琥珀酸钠冻干粉针剂及其制备方法 Two kinds of methylprednisolone sodium succinate freeze-dried powder and its preparation method
12/28/2011	CN102293752A 壳聚糖载辣椒素微球制备方法及微球和减肥降脂以及降糖应用 Capsaicin contained chitosan microsphere preparation method and microspheres and lipid-lowering diet and hypoglycemic application
12/28/2011	CN102293751A 一种用于抗癌药物释放的壳聚糖微球的制备方法 An anticancer drug release chitosan microspheres prepared for
12/28/2011	CN102293750A 马钱子碱免疫纳米微粒用于制备抗肝癌靶向药物的用途 Use strychnine immune nanoparticles used in the preparation of anti-liver-targeted drugs

1 ... 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 ... 1712